Clinical Trial Update: Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders

View source ↗

Summary

A completed NIH-backed clinical trial examining molecular changes and biomarkers in chronic myeloproliferative disorders including polycythemia vera, essential …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Myelofibrosis
• Myeloproliferative Neoplasms
• Polycythemia Vera

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Polycythemia Vera, Essential Thrombocytosis | Status: COMPLETED